Asked by: Graeme Morrice (Labour - Livingston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate he has made of the number of healthcare professionals who (a) are aware of and (b) use the databases of the British Society of Urogynaecology and the British Association of Urological Surgeons to record adverse effects in transvaginal mesh implants.
Answered by Norman Lamb
The Department, NHS England and the Medicines and Healthcare products Regulatory Agency (MHRA) have been working collaboratively to address the serious concerns that have been raised about transvaginal mesh implants. A working group has been set up to discuss these and will cover a range of issues including better collection and coordination of information on patients outcomes including complications, incident reporting and the need for a register. It will also consider how the British Society of Urogynaecology/ the British Association of Urological Surgeons databases can assist in providing information on the use of transvaginal mesh implants, patient outcomes and complications and the use of these databases by professionals. The working group will also look at ways of working with devolved administrations to improve incident reporting to the MHRA and the development of patient consent forms.
Asked by: Graeme Morrice (Labour - Livingston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what representations he has received from (a) patients, (b) professional bodies, (c) the MHRA and (d) mesh manufacturers on the use of the databases of the British Society of Urogynaecology and British Association of Urological Surgeons to record adverse effects in transvaginal mesh implants.
Answered by Norman Lamb
The Department, NHS England and the Medicines and Healthcare products Regulatory Agency (MHRA) have been working collaboratively to address the serious concerns that have been raised about transvaginal mesh implants. A working group has been set up to discuss these and will cover a range of issues including better collection and coordination of information on patients outcomes including complications, incident reporting and the need for a register. It will also consider how the British Society of Urogynaecology/ the British Association of Urological Surgeons databases can assist in providing information on the use of transvaginal mesh implants, patient outcomes and complications and the use of these databases by professionals. The working group will also look at ways of working with devolved administrations to improve incident reporting to the MHRA and the development of patient consent forms.
Asked by: Graeme Morrice (Labour - Livingston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment his Department has made as to the accuracy of the databases of the British Society of Urogynaecology and British Association of Urological Surgeons as indicators of the total number of adverse effects in transvaginal mesh implants.
Answered by Norman Lamb
The Department, NHS England and the Medicines and Healthcare products Regulatory Agency (MHRA) have been working collaboratively to address the serious concerns that have been raised about transvaginal mesh implants. A working group has been set up to discuss these and will cover a range of issues including better collection and coordination of information on patients outcomes including complications, incident reporting and the need for a register. It will also consider how the British Society of Urogynaecology/ the British Association of Urological Surgeons databases can assist in providing information on the use of transvaginal mesh implants, patient outcomes and complications and the use of these databases by professionals. The working group will also look at ways of working with devolved administrations to improve incident reporting to the MHRA and the development of patient consent forms.
Asked by: Graeme Morrice (Labour - Livingston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what consideration he has given to making the reporting of adverse effects in transvaginal mesh implants mandatory.
Answered by Norman Lamb
The Department, NHS England and the Medicines and Healthcare products Regulatory Agency (MHRA) have been working collaboratively to address the serious concerns that have been raised about transvaginal mesh implants. A working group has been set up to discuss these and will cover a range of issues including better collection and coordination of information on patients outcomes including complications, incident reporting and the need for a register. It will also consider how the British Society of Urogynaecology/ the British Association of Urological Surgeons databases can assist in providing information on the use of transvaginal mesh implants, patient outcomes and complications and the use of these databases by professionals. The working group will also look at ways of working with devolved administrations to improve incident reporting to the MHRA and the development of patient consent forms.
Asked by: Graeme Morrice (Labour - Livingston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what representation he has received from (a) patients, (b) professional bodies, (c) the MHRA and (d) mesh manufacturers on a mandatory adverse effect register for transvaginal mesh implants.
Answered by Norman Lamb
The Department, NHS England and the Medicines and Healthcare products Regulatory Agency (MHRA) have been working collaboratively to address the serious concerns that have been raised about transvaginal mesh implants. A working group has been set up to discuss these and will cover a range of issues including better collection and coordination of information on patients outcomes including complications, incident reporting and the need for a register. It will also consider how the British Society of Urogynaecology/ the British Association of Urological Surgeons databases can assist in providing information on the use of transvaginal mesh implants, patient outcomes and complications and the use of these databases by professionals. The working group will also look at ways of working with devolved administrations to improve incident reporting to the MHRA and the development of patient consent forms.
Asked by: Graeme Morrice (Labour - Livingston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what plans his Department has to (a) commission research on, (b) consult on and (c) introduce a standard patient consent form for transvaginal mesh implants.
Answered by Norman Lamb
The Department, NHS England and the Medicines and Healthcare products Regulatory Agency (MHRA) have been working collaboratively to address the serious concerns that have been raised about transvaginal mesh implants. A working group has been set up to discuss these and will cover a range of issues including better collection and coordination of information on patients outcomes including complications, incident reporting and the need for a register. It will also consider how the British Society of Urogynaecology/ the British Association of Urological Surgeons databases can assist in providing information on the use of transvaginal mesh implants, patient outcomes and complications and the use of these databases by professionals. The working group will also look at ways of working with devolved administrations to improve incident reporting to the MHRA and the development of patient consent forms.
Asked by: Graeme Morrice (Labour - Livingston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what discussions his Department has had about transvaginal mesh implants with (a) the Scottish Government, (b) NHS Scotland, (c) NHS England and (d) NHS Wales in the last three years.
Answered by Norman Lamb
The Department, NHS England and the Medicines and Healthcare products Regulatory Agency (MHRA) have been working collaboratively to address the serious concerns that have been raised about transvaginal mesh implants. A working group has been set up to discuss these and will cover a range of issues including better collection and coordination of information on patients outcomes including complications, incident reporting and the need for a register. It will also consider how the British Society of Urogynaecology/ the British Association of Urological Surgeons databases can assist in providing information on the use of transvaginal mesh implants, patient outcomes and complications and the use of these databases by professionals. The working group will also look at ways of working with devolved administrations to improve incident reporting to the MHRA and the development of patient consent forms.
Asked by: Graeme Morrice (Labour - Livingston)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, how many formal client complaints were brought against Jobcentre Plus staff in (a) the UK, (b) Scotland, (c) West Lothian local authority area and (d) Livingston constituency in each of the last five years.
Answered by Esther McVey - Minister without Portfolio (Cabinet Office)
The information requested is not available prior to July 2010, however data is available as follows:
July 2010 – March 2011 | April 2011 – March 2012 | April 2012 – March 2013 | April 2013 – March 2014 | |
Scotland | 815 | 1,070 | 983 | 773 |
National (England, Scotland & Wales) | 6,180 | 8,979 | 16,864 | 15,481 |
DWP completed the incremental roll-out of a new complaints process in December 2012 which encouraged the recording of complaints. The data provided spans both processes.
As complaints are not recorded by local authority area or constituency, this level of data isn't available.
Asked by: Graeme Morrice (Labour - Livingston)
Question to the Ministry of Defence:
To ask the Secretary of State for Defence, whether his Department has any plans to end the employee trade union membership dues check-off system.
Answered by Anna Soubry
I refer the hon. Member to the answer given by the Minister for Defence Equipment, Science, and Technology (Mr Philip Dunne) on 2 April 2014 (Official Report, column 730W) to the hon. Member for Leicester South (Mr Jonathan Ashworth).
Asked by: Graeme Morrice (Labour - Livingston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department has taken to address patient concerns regarding the use of transvaginal mesh implants.
Answered by Norman Lamb
Work to improve outcomes for women undergoing procedures involving urethral tape and vaginal mesh is currently under way and is being led by NHS England. The Department is involved in this work alongside the Medicines and Healthcare products Regulatory Agency (MHRA), the specialist societies (The British Society of Urogynaecology (BSUG) and The British Association of Urological Surgeons (BAUS)) and the Royal College of Obstetricians and Gynaecologists.
In addition, Professor Sir Bruce Keogh, Medical Director, NHS England has written to the National Health Service to highlight the need to ensure that
- National Institute for Health and Care Excellence guidance for these procedures is followed;
- consent procedures are standardised so that they comply with up to date evidence and follow BSUG and BAUS guidance;
- all pelvic organ prolapse procedures and all incontinence operations, but particularly those involving mesh, are recorded on a recognised database e.g. the BSUG or BAUS surgical databases;
- all adverse events are reported to MHRA; and
- surgery for removal of tapes or prolapse mesh or repeat surgery for incontinence or prolapse is performed in units which can demonstrate relevant specialist care.